Treatment of Metabolic Syndrome in a Community Mental Health Center

Completed · Not applicable

Conditions studied: Serious Mental Illness

In brief

The purpose of this study is to learn if patients being treated with second generation antipsychotics and with clinically meaningful elevations/levels in any metabolic syndrome elements will have better access to medical treatment more quickly if they are randomized to one of the following conditions: 1) a primary care provider located in the community mental health center where mental health treatment is provided (IMBED), 2) a medical care manager to help coordinate treatment with an outside primary care provider (Liaison) or 3) the standard practice of advising the patient to see a primary care doctor (Treatment as Usual).

Key facts

Study ID

NCT01115114

Run by

The University of Texas Health Science Center at San Antonio

People needed

130

Starts

2009-01-01

Expected to finish

2014-01-01

Last updated by the study team

2015-02-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Males and Females 18 years and older
• Active CMHC consumers
• Currently taking an atypical antipsychotic
• Identified as having clinically meaningful elevations/levels in metabolic indicators; i.e. fasting blood glucose (≥ 110), HDL ≤ 40mg/dl for males or ≤ 50mg/dl for females, blood pressure (≥ 130/85)
• Able to give informed consent
• Recipient of private or publicly-financed health insurance that includes medication coverage

You may not qualify if…

• Legally declared mentally incompetent (guardians will not be approached about study)

Where it is running

• Center for Health Care Services — San Antonio, Texas, United States
• University of Texas Health Science Center at San Antonio — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.